Dr Charles J Starrett, DPM | |
2250 Hayes Street, Ste 501, San Francisco, CA 94117 | |
(415) 831-2885 | |
(415) 831-2886 |
Full Name | Dr Charles J Starrett |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | 2250 Hayes Street, San Francisco, California |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1023120565 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
213E00000X | Podiatrist | 000E37430 (California) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Charles J Starrett, DPM 2250 Hayes Street, Ste 501, San Francisco, CA 94117 Ph: (415) 831-2885 | Dr Charles J Starrett, DPM 2250 Hayes Street, Ste 501, San Francisco, CA 94117 Ph: (415) 831-2885 |
News Archive
"The House Energy and Commerce Committee resumed work Thursday on major health care legislation, voting to establish a government-run health insurance plan, as top Republicans stepped up their criticism of the ambitious legislation," The New York Times reports.
With summer in full effect, people are participating in outdoor activities to reach their fitness goals. Research shows that using a pedometer can increase physical activity and can be a great motivational tool to help people reach the recommended 10,000 steps a day. Today Omron Healthcare, Inc., a leader in health & wellness products, announced the release of two new pedometers, the Omron HJ-320 and HJ-321.
The third edition of the Ontario Cancer Plan (OCP) ensures our cancer system serves the changing and growing needs of Ontarians. The Cancer Plan outlines priorities for cancer services, sets a course to transform cancer services from the patient perspective, and is driven by a commitment to quality across the cancer journey - from prevention to survivorship or palliative care - as the most effective way to manage cancer.
Merck, known as MSD outside the United States and Canada, announced today that the New Drug Application for SAFLUTAN, Merck's investigational preservative-free prostaglandin analogue ophthalmic solution, has been accepted for standard review by the U.S. Food and Drug Administration.
The U.S. Food and Drug Administration (FDA) has approved the first blood test designed to help predict a patient's risk for ischemic stroke, the most common type of stroke and one of the nation's leading causes of long-term disability affecting approximately 700,000 people per year.
› Verified 5 days ago
Wilson C A Dunn, DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 2480 Mission St, #104, San Francisco, CA 94110 Phone: 415-648-2810 Fax: 415-648-5888 | |
Noel Stephen Obrien, DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 3801 Sacramento Street, Suite 621, San Francisco, CA 94118 Phone: 415-600-4000 Fax: 415-600-4005 | |
Dr. Mark Edward Pinter, DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 490 Post St, Suite 450, San Francisco, CA 94102 Phone: 415-781-4833 Fax: 415-781-3361 | |
Dr. Charles Brian Parks, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 2550 23rd St, Building 9, 2nd Floor, San Francisco, CA 94110 Phone: 415-206-8812 | |
Dr. Bill Morley Jenkin Jr., DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 2250 Hayes St, Suite 4a, San Francisco, CA 94117 Phone: 415-759-2014 Fax: 415-759-2015 | |
Dr. Alexander Reyzelman, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 2299 Post St, Ste 205, San Francisco, CA 94115 Phone: 415-292-0638 |